Ballicules.com

Nefazodone

SERZONE

What it isSerotonin 5-HT2 antagonist and reuptake inhibitor; depression.

Why this oneIt causes little sexual dysfunction and does not suppress REM sleep, unlike most antidepressants.

What limits itRare but fatal hepatic failure ended its widespread use. A strong CYP3A4 inhibitor.

FDA-approved for

FDA label

BOXED WARNING Suicidality — increased risk of suicidal thinking/behavior in children, adolescents, and young adults; not approved for pediatric use
FDA dosingPopulationStartTargetMax
DepressionAdults200 mg/day BID300–600 mg/day BID600 mg/day
DepressionElderly/debilitated100 mg/day BIDtitrate to response600 mg/day

Titration Increase in increments of 100–200 mg/day at intervals of no less than 1 week

Renal Undefined

Hepatic Undefined (contraindicated if prior nefazodone-associated liver injury)

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Category C; use only if potential benefit justifies risk to fetus

Lactation Undefined

⚠ BOXED WARNINGS

Cost, est. cash$10–$300/month

Generic entry2003

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Overdose danger2 / 4
Weight-gain liability1 / 4
Sedation liability1 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityRare but potentially fatal hepatic failure and clinically important CYP3A inhibition.

Active metabolites

Mechanism of action: Nefazodone ballicule

Nefazodone ballicule: receptor binding, kinetics and half-life diagram

Open Nefazodone in the interactive console ↗

Memory aids: mascots and interaction avatars

Nefazodone SERZONE mascot mnemonic cartoon
“Neph’s Sear zone / Nefarious Sear zone”
Strong CYP3A4 inHibitor
Boxed warning: acute liver failure
Nefazodone CYP3A4 inhibitor avatar
CYP3A4 inhibitor (strong)

Open Nefazodone in the interactive console ↗